János György Pitter,Balázs Szatmári,Marc Debelle,György József Németh,István Laszlovszky
申请号:
US14646226
公开号:
US20150306094A1
申请日:
2013.11.28
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of primary negative symptoms of schizophrenia and/or predominantly negative symptoms of schizophrenia.